Cargando…

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season

Detalles Bibliográficos
Autores principales: Grohskopf, Lisa A., Sokolow, Leslie Z., Fry, Alicia M., Walter, Emmanuel B., Jernigan, Daniel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991811/
https://www.ncbi.nlm.nih.gov/pubmed/29879095
http://dx.doi.org/10.15585/mmwr.mm6722a5
_version_ 1783329907222249472
author Grohskopf, Lisa A.
Sokolow, Leslie Z.
Fry, Alicia M.
Walter, Emmanuel B.
Jernigan, Daniel B.
author_facet Grohskopf, Lisa A.
Sokolow, Leslie Z.
Fry, Alicia M.
Walter, Emmanuel B.
Jernigan, Daniel B.
author_sort Grohskopf, Lisa A.
collection PubMed
description
format Online
Article
Text
id pubmed-5991811
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-59918112018-06-13 Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season Grohskopf, Lisa A. Sokolow, Leslie Z. Fry, Alicia M. Walter, Emmanuel B. Jernigan, Daniel B. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2018-06-08 /pmc/articles/PMC5991811/ /pubmed/29879095 http://dx.doi.org/10.15585/mmwr.mm6722a5 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Grohskopf, Lisa A.
Sokolow, Leslie Z.
Fry, Alicia M.
Walter, Emmanuel B.
Jernigan, Daniel B.
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
title Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
title_full Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
title_fullStr Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
title_full_unstemmed Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
title_short Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
title_sort update: acip recommendations for the use of quadrivalent live attenuated influenza vaccine (laiv4) — united states, 2018–19 influenza season
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991811/
https://www.ncbi.nlm.nih.gov/pubmed/29879095
http://dx.doi.org/10.15585/mmwr.mm6722a5
work_keys_str_mv AT grohskopflisaa updateaciprecommendationsfortheuseofquadrivalentliveattenuatedinfluenzavaccinelaiv4unitedstates201819influenzaseason
AT sokolowlesliez updateaciprecommendationsfortheuseofquadrivalentliveattenuatedinfluenzavaccinelaiv4unitedstates201819influenzaseason
AT fryaliciam updateaciprecommendationsfortheuseofquadrivalentliveattenuatedinfluenzavaccinelaiv4unitedstates201819influenzaseason
AT walteremmanuelb updateaciprecommendationsfortheuseofquadrivalentliveattenuatedinfluenzavaccinelaiv4unitedstates201819influenzaseason
AT jernigandanielb updateaciprecommendationsfortheuseofquadrivalentliveattenuatedinfluenzavaccinelaiv4unitedstates201819influenzaseason